Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19

Stopped Unable to recruit participants due to restrictive inclusion/exclusion criteria. Will update protocol with IRB \& begin anew after approval.

Conditions

• Covid19

Interventions

• DRUG: Metformin
• DRUG: Naltrexone

Sponsor

AgelessRx